Pacific Biosciences
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell PACB and other ETFs, options, and stocks.About PACB
Pacific Biosciences of California, Inc. engages in the development, manufacture, and marketing of advanced sequencing solutions for genetic analysis. It operates through the following geographical segments: America, Europe, Middle East, and Africa, and Asia Pacific.
CEOChristian O. Henry
CEOChristian O. Henry
Employees796
Employees796
HeadquartersMenlo Park, California
HeadquartersMenlo Park, California
Founded2000
Founded2000
Employees796
Employees796
PACB Key Statistics
Market cap368.94M
Market cap368.94M
Price-Earnings ratio-1.12
Price-Earnings ratio-1.12
Dividend yield—
Dividend yield—
Average volume18.93M
Average volume18.93M
High today$1.53
High today$1.53
Low today$1.35
Low today$1.35
Open price$1.51
Open price$1.51
Volume11.06M
Volume11.06M
52 Week high$14.55
52 Week high$14.55
52 Week low$1.25
52 Week low$1.25
PACB News
Yahoo Finance 2d
Pacific Biosciences Upgraded to Buy: Here's What You Should Know - Yahoo FinancePacific Biosciences of California (PACB) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially r...
Seeking Alpha 3d
PacBio moved to Neutral at JPMorgan after guidance cutPacBio (NASDAQ:PACB) is facing yet another downgrade after the gene sequencing company lowered its full-year outlook, while missing Q1 results. JPMorgan downgr...
Seeking Alpha 7d
PacBio cut to Neutral at Goldman Sachs after guidance cutGoldman Sachs downgraded its recommendation on PacBio (NASDAQ:PACB) on Thursday after the gene sequencing company lowered its full-year guidance below consensus...
Analyst ratings
64%
of 14 ratingsBuy
35.7%
Hold
64.3%
Sell
0%
More PACB News
Simply Wall St 7d
Pacific Biosciences of California, Inc. Analysts Just Slashed This Year's Revenue Estimates By 18%Market forces rained on the parade of Pacific Biosciences of California, Inc. (NASDAQ:PACB) shareholders today, when the analysts downgraded their forecasts for...
